125 related articles for article (PubMed ID: 21476304)
1. [Recent progress in understanding the molecular pathogenesis of diabetic nephropathy].
Abe H
Rinsho Byori; 2011 Feb; 59(2):179-86. PubMed ID: 21476304
[TBL] [Abstract][Full Text] [Related]
2. Role of Smad1 in diabetic nephropathy: Molecular mechanisms and implications as a diagnostic marker.
Abe H; Matsubara T; Arai H; Doi T
Histol Histopathol; 2011 Apr; 26(4):531-41. PubMed ID: 21360446
[TBL] [Abstract][Full Text] [Related]
3. The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy.
Doi T; Mima A; Matsubara T; Tominaga T; Arai H; Abe H
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S21-4. PubMed ID: 18842318
[TBL] [Abstract][Full Text] [Related]
4. Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy.
Mima A; Arai H; Matsubara T; Abe H; Nagai K; Tamura Y; Torikoshi K; Araki M; Kanamori H; Takahashi T; Tominaga T; Matsuura M; Iehara N; Fukatsu A; Kita T; Doi T
Diabetes; 2008 Jun; 57(6):1712-22. PubMed ID: 18285555
[TBL] [Abstract][Full Text] [Related]
5. Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy.
Matsubara T; Abe H; Arai H; Nagai K; Mima A; Kanamori H; Sumi E; Takahashi T; Matsuura M; Iehara N; Fukatsu A; Kita T; Doi T
Lab Invest; 2006 Apr; 86(4):357-68. PubMed ID: 16482100
[TBL] [Abstract][Full Text] [Related]
6. Activation of bone morphogenetic protein 4 signaling leads to glomerulosclerosis that mimics diabetic nephropathy.
Tominaga T; Abe H; Ueda O; Goto C; Nakahara K; Murakami T; Matsubara T; Mima A; Nagai K; Araoka T; Kishi S; Fukushima N; Jishage K; Doi T
J Biol Chem; 2011 Jun; 286(22):20109-16. PubMed ID: 21471216
[TBL] [Abstract][Full Text] [Related]
7. The role of the BMP4/Smad1 signaling pathway in mesangial cell proliferation: A possible mechanism of diabetic nephropathy.
Chen C; Lin J; Li L; Zhu T; Gao L; Wu W; Liu Q; Ou S
Life Sci; 2019 Mar; 220():106-116. PubMed ID: 30708099
[TBL] [Abstract][Full Text] [Related]
8. Camel milk attenuates the biochemical and morphological features of diabetic nephropathy: inhibition of Smad1 and collagen type IV synthesis.
Korish AA; Abdel Gader AG; Korashy HM; Al-Drees AM; Alhaider AA; Arafah MM
Chem Biol Interact; 2015 Mar; 229():100-8. PubMed ID: 25617480
[TBL] [Abstract][Full Text] [Related]
9. Type IV collagen is transcriptionally regulated by Smad1 under advanced glycation end product (AGE) stimulation.
Abe H; Matsubara T; Iehara N; Nagai K; Takahashi T; Arai H; Kita T; Doi T
J Biol Chem; 2004 Apr; 279(14):14201-6. PubMed ID: 14732718
[TBL] [Abstract][Full Text] [Related]
10. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
11. The involvement of advanced glycation endproducts (AGEs) in renal injury of diabetic glomerulosclerosis: association with phenotypic change in renal cells and infiltration of immune cells.
Mao Y; Ootaka T; Saito T; Sato H; Sato T; Ito S
Clin Exp Nephrol; 2003 Sep; 7(3):201-9. PubMed ID: 14586716
[TBL] [Abstract][Full Text] [Related]
12. All-trans retinoic acid suppresses bone morphogenetic protein 4 in mouse diabetic nephropathy through a unique retinoic acid response element.
Tamaki M; Tominaga T; Fujita Y; Koezuka Y; Ichien G; Murakami T; Kishi S; Yamamoto K; Abe H; Nagai K; Doi T
Am J Physiol Endocrinol Metab; 2019 Mar; 316(3):E418-E431. PubMed ID: 30601699
[TBL] [Abstract][Full Text] [Related]
13. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy.
Uehara G; Suzuki D; Toyoda M; Umezono T; Sakai H
Clin Exp Nephrol; 2004 Mar; 8(1):36-42. PubMed ID: 15067514
[TBL] [Abstract][Full Text] [Related]
14. [Abnormality of type IV collagen metabolism in the development of diabetic nephropathy].
Haneda M; Kikkawa R
Nihon Rinsho; 1992 Dec; 50(12):3016-20. PubMed ID: 1491453
[TBL] [Abstract][Full Text] [Related]
15. Bone Morphogenetic Protein 4 and Smad1 Mediate Extracellular Matrix Production in the Development of Diabetic Nephropathy.
Matsubara T; Araki M; Abe H; Ueda O; Jishage K; Mima A; Goto C; Tominaga T; Kinosaki M; Kishi S; Nagai K; Iehara N; Fukushima N; Kita T; Arai H; Doi T
Diabetes; 2015 Aug; 64(8):2978-90. PubMed ID: 25995358
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy.
Mima A; Matsubara T; Arai H; Abe H; Nagai K; Kanamori H; Sumi E; Takahashi T; Iehara N; Fukatsu A; Kita T; Doi T
Lab Invest; 2006 Sep; 86(9):927-39. PubMed ID: 16767106
[TBL] [Abstract][Full Text] [Related]
17. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of diabetic nephropathy.
Raptis AE; Viberti G
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S424-37. PubMed ID: 11460589
[TBL] [Abstract][Full Text] [Related]
19. Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice.
Cohen MP; Lautenslager GT; Shearman CW
Metabolism; 2001 Dec; 50(12):1435-40. PubMed ID: 11735089
[TBL] [Abstract][Full Text] [Related]
20. SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice.
Sugaru E; Nakagawa T; Ono-Kishino M; Nagamine J; Tokunaga T; Kitoh M; Hume WE; Nagata R; Taiji M
Am J Physiol Renal Physiol; 2006 Apr; 290(4):F813-20. PubMed ID: 16278277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
